tiprankstipranks
Trending News
More News >
Achieve Life Sciences (ACHV)
NASDAQ:ACHV
US Market

Achieve Life Sciences (ACHV) Financial Statements

Compare
1,749 Followers

Achieve Life Sciences Financial Overview

Achieve Life Sciences's market cap is currently $215.60M. The company's EPS TTM is $; its P/E ratio is -1.89; Achieve Life Sciences is scheduled to report earnings on March 24, 2026, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -229.00K$ 0.00$ 0.00$ 0.00$ -255.00K
Operating Income$ -39.07M$ -27.25M$ -40.80M$ -33.09M$ -14.75M
EBITDA$ -37.42M$ -26.73M$ -40.33M$ -32.90M$ -14.47M
Net Income$ -39.83M$ -29.82M$ -42.35M$ -33.15M$ -14.66M
Balance Sheet
Cash & Short-Term Investments$ 34.36M$ 15.55M$ 24.72M$ 43.02M$ 35.85M
Total Assets$ 38.63M$ 19.37M$ 29.97M$ 47.52M$ 40.30M
Total Debt$ 9.96M$ 16.73M$ 16.20M$ 14.99M$ 169.00K
Net Debt$ -2.79M$ 1.19M$ -8.52M$ -28.03M$ -35.68M
Total Liabilities$ 17.73M$ 20.82M$ 21.67M$ 19.47M$ 3.01M
Stockholders' Equity$ 20.90M$ -1.45M$ 8.30M$ 28.04M$ 37.29M
Cash Flow
Free Cash Flow$ -29.77M$ -24.50M$ -37.57M$ -29.44M$ -13.49M
Operating Cash Flow$ -29.77M$ -24.48M$ -37.57M$ -29.44M$ -13.47M
Investing Cash Flow$ -21.58M$ -21.00K$ 0.00$ 0.00$ -17.00K
Financing Cash Flow$ 48.53M$ 15.28M$ 19.32M$ 36.61M$ 32.68M
Currency in USD

Achieve Life Sciences Earnings and Revenue History

Achieve Life Sciences Debt to Assets

Achieve Life Sciences Cash Flow

Achieve Life Sciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.